|
|
 |
|
Viewing report
|
|
|
|
Apoteket AB Oct 06
Standard & Poors, Oct 2006
Abstract
Dominant market position likely to continue. Strong consumer franchise and recognized expertise in pharmaceutical distribution. Likelihood of extraordinary government support in case of financial distress. Uncertainty regarding the upcoming deregulation of the pharmaceutical market, and possible privatization. Limited financial flexibility in the face of future competition. The ratings on Swedish state-owned pharmaceutical monopoly retailer Apoteket AB reflect its dominant market position, its strong consumer franchise, and the likelihood of extraordinary government support in case of financial distress. They also reflect the uncertainty regarding the impact of the upcoming deregulation of the market on Apoteket, as well as the company's limited financial flexibility in the face of future competition. The new Swedish center-right majority government, which recently took office, announced in...
Companies mentioned in this report are: Apoteket AB,Sweden (Kingdom of)
Action: Review
Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.
Research Type: Full Analysis
|
|
|
|
